Should old acquaintance be forgot: A call for recognition and inclusion of advanced Parkinson's disease patients & care partners in evolving research models.
Jade S Park, Claire Pensyl, Thomas J Manak, Jori E Fleisher
Article in Parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Jade S ParkDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Claire PensylPERSEVERE Care Partner Advisor Panel, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Thomas J ManakPERSEVERE Care Partner Advisor Panel, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Jori E FleisherDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA. Electronic address: jori_fleisher@rush.edu.
Funding
Statistics CoreU19AG078105 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MANISH N SHAH · 2023 to 2026
$58.3M
Dementia with Lewy Bodies Consortium - Supplement for ASL sequenceU01NS100610 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI DOUGLAS R GALASKO, JAMES Bruce LEVERENZ · 2016 to 2026
$15.6M
Roybal Translational Research Center to Promote Context-Specific Caregiving of Community-Dwelling Persons Living with Alzheimer's Disease or Related DisordersP30AG064200 · NIA · EMORY UNIVERSITY · PI Fayron Recha Epps · 2019 to 2026
$8.6M
PERSEVERE in Lewy Body Dementia: A Randomized, Controlled Trial of Peer Mentor Support and Caregiver EducationR01AG079128 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Jori Erin Fleisher · 2023 to 2026
$2.8M
Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's DiseaseK23NS097615 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI FLEISHER, JORI ERIN · 2017 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Should old acquaintance be forgot: A call for recognition and inclusion of advanced Parkinson's disease patients & care partners in evolving research models. · full record | OpenQuestion